Index trend and stocks in action June 01, 2017
Chirag Gothi / 01 Jun 2017
Now going forward Nifty has resistance placed around levels of 9645-9650 and if it holds above levels of 9645-9650 it’s likely to open up for up-move up to levels of 9680-9700. On the downside, supports are seen at levels of 9550 and 9500.
On Wednesday, Nifty opened the session on a subdued note and thereafter it kept oscillating in a narrow range for the most part of the trading session. On the daily chart Nifty had formed a small body negative candle, this candle does not have any significant predictive value, and however, it does suggest that after four days of up-move bulls took a breather. Now going forward Nifty has resistance placed around levels of 9645-9650 and if it holds above levels of 9645-9650 it’s likely to open up for up-move up to levels of 9680-9700. On the downside, supports are seen at levels of 9550 and 9500.
Brigade Enterprises: Rating Committee of ICRA, after due consideration, has reaffirmed the long-term rating for the captioned Line of Credit (LOC) at [ICRA] A. The outlook on the long-term rating has been revised from Negative to Stable.
Cadila Healthcare: Zydus receives final approval from the USFDA for Felbamate Tablets USP.
Kolte-Patil Developers: Kolte-Patil a leading real estate developers, has completed Phase I of its ‘Three Jewels' Project in Pune in 36 months.
JK Paper: Intimation regarding Meeting of the Committee of Directors of the Company to be held on Thursday, 8th June 2017, to consider allotment of Equity Shares of the Company consequent to conversion notices received from one of the Foreign Currency Convertible Bonds (FCCBs) Holder, seeking conversion of its FCCBs (Series 4) & FCCBs (Series 5) of Euro 2.4 million each into Equity Shares of the Company.
Bharat Gears: To avail a term loan of Rs 110 crore from KKR India Financial Services to repay its existing term debts, working capital requirements and capital expenditure.
Pfizer: the Company has entered into an Acquisition Agreement with AstraZeneca AB, Sweden ('AstraZeneca'), pursuant to which the brand 'Neksium' is being acquired by the Company in India for a consideration of Rs. 75 Crores, subject to completion of necessary conditions precedent. Neksium (esomeprazole) complements the Company's existing product portfolio in the gastrointestinal (GI) therapeutic area.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.